Stanford developing single-dose nanoparticle vaccine for COVID-19 January 7, 2021 Hans Le Roy Post navigation Previous PostNew virtual screening strategy identifies existing drug that inhibits COVID-19 virusNext PostImmune response to COVID-19 reduced in patients with blood cancers